Sepsis-induced selective parvalbumin interneuron phenotype loss and cognitive impairments may be mediated by NADPH oxidase 2 activation in mice

J Neuroinflammation. 2015 Sep 29:12:182. doi: 10.1186/s12974-015-0401-x.

Abstract

Background: Sepsis-associated encephalopathy (SAE) is a diffuse brain dysfunction caused by many pathological events, including neuroinflammation and oxidative stress damage. Increasing evidence suggests that parvalbumin (PV) interneurons play a key role in the cognitive process, whereas the dysfunction of these interneurons has been implicated in a number of major psychiatric disorders. Here, we aimed to investigate whether enhanced inflammation and oxidative stress-mediated PV interneuron phenotype loss plays a role in sepsis-induced cognitive impairments.

Methods: Male C57BL/6 mice were subjected to cecal ligation and puncture or sham operation. For the interventional study, the animals were chronically treated with a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor, apocynin, at 5 mg/kg. The mice were euthanized at the indicated time points, and the brain tissues were harvested for determination of the PV, membrane subunit of NADPH oxidase gp91(phox), and markers of oxidative stress (4-hydroxynonenal and malondialdehyde) and inflammation (tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, IL-6, and IL-10). A separate cohort of animals was used to evaluate the behavioral alterations by the open field and fear conditioning tests. Primary hippocampal neuronal cultures were used to investigate the mechanisms underlying the dysfunction of PV interneurons.

Results: Sepsis resulted in cognitive impairments, which was accompanied by selective phenotype loss of PV interneurons and increased gp91(phox), 4-hydroxynonenal, malondialdehyde, IL-1β, and IL-6 expressions. Notably, these abnormalities could be rescued by apocynin treatment.

Conclusion: Selective phenotype loss of PV interneurons, as a result of NADPH oxidase 2 (Nox2) activation, might partly contribute to cognitive impairments in a mouse model of SAE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetophenones / pharmacology
  • Acetophenones / therapeutic use
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Cells, Cultured
  • Cognition Disorders / etiology*
  • Conditioning, Psychological / drug effects
  • Disease Models, Animal
  • Exploratory Behavior / drug effects
  • Fear / psychology
  • Hippocampus / cytology
  • Interneurons / metabolism*
  • Male
  • Malondialdehyde / metabolism
  • Membrane Glycoproteins / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • NADPH Oxidase 2
  • NADPH Oxidases / metabolism*
  • Neurons / drug effects
  • Neurons / metabolism
  • Oxidative Stress / drug effects
  • Parvalbumins / metabolism*
  • Sepsis / complications*
  • Sepsis / drug therapy
  • Sepsis / pathology*
  • Superoxide Dismutase / metabolism

Substances

  • Acetophenones
  • Anti-Inflammatory Agents, Non-Steroidal
  • Membrane Glycoproteins
  • Parvalbumins
  • Malondialdehyde
  • acetovanillone
  • Superoxide Dismutase
  • Cybb protein, mouse
  • NADPH Oxidase 2
  • NADPH Oxidases